Pfizer has announced the withdrawal of all lots of Oxbryta, its drug for sickle cell disease, amid concerns about increased complications and fatal events.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Pfizer yanks all lots of sickle cell disease drug from market
